Fundoscopy-directed genetic testing to re-evaluate negative whole exome sequencing results

Fundoscopy-directed genetic testing to re-evaluate negative whole exome sequencing results

Abstract Background Whole exome sequencing (WES) allows for an unbiased search of the genetic cause of a disease. Employing it as a first-tier genetic testing can be favored due to the associated lower incremental cost per diagnosis compared to when using it later in the diagnostic pathway. However,...

Full description

Bibliographic Details
Main Authors: Ahra Cho, Jose Ronaldo Lima de Carvalho, Akemi J. Tanaka, Ruben Jauregui, Sarah R. Levi, Alexander G. Bassuk, Vinit B. Mahajan, Stephen H. Tsang
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Whole exome sequencing
Inherited retinal diseases
Fundoscopy
Gene therapy
Whole genome sequencing
Online Access:https://doi.org/10.1186/s13023-020-1312-1

Internet

https://doi.org/10.1186/s13023-020-1312-1

Similar Items